MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ULCC stock logo

ULCC

Frontier Group Holdings, Inc.

$6.35
0.36
 (6.01%)
Exchange:  NASDAQ
Market Cap:  1.459B
Shares Outstanding:  214.26M
Delayed data
Calculate ULCC Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Industrials
Industry:  Airlines, Airports & Air Services
   
CEO:  James G. Dempsey
Full Time Employees:  7906
Address: 
4545 Airport Way
Denver
CO
80239
US
Website:  https://www.flyfrontier.com
Operating as an ultra-low-cost carrier, Frontier Group Holdings, Inc. facilitates air travel for passengers. Its flight network spans approximately 120 airports, reaching destinations throughout the United States and internationally across the Americas. The company provides its services directly to consumers via its website, mobile app, and call center. By the close of 2021, specifically December 31st, its operational fleet comprised 110 single-aisle Airbus aircraft, including 16 A320ceos, 73 A320neos, and 21 A321ceos. Frontier Group Holdings, Inc. was founded in 2013 and maintains its headquarters in Denver, Colorado.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/01 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue3,589,0003,775,0003,724,000
Gross Profit302,0001,937,0001,322,000
EBITDA83,000122,000-58,000
Operating Income-3,00058,000-149,000
Net Income-11,00085,000-137,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets4,993,0006,153,0007,220,000
Total Liabilities4,486,0005,549,000-434,000
Total Stockholders Equity507,000604,000434,000
Total Debt3,459,0004,468,0000
Cash and Cash Equivalents609,000740,000671,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-261,00000
Capital Expenditure-87,000-73,000-99,000
Free Cash Flow-348,000-73,000-99,000
Net Income-11,00085,000-137,000
Net Change in Cash-152,000131,000-740,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)5,527,168.732Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)5,621,788.364Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)5,574,478.548Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)113,279.759Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)115,218.996Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)114,249.378Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)138,237.285Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)155,708.108Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)146,972.697Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)262,833.038Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)267,332.478Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)265,082.758Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.630Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.680Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.600Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)4Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
3.775B  ?P/S
 (TTM)
: 
0.36
?Net Income
 (TTM)
: 
84M  ?P/E
 (TTM)
: 
-3.71
?Enterprise Value
 (TTM)
: 
5.841B  ?EV/FCF
 (TTM)
: 
-12.14
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.89  ?ROIC
 (TTM)
: 
-0.07
?Net Debt
 (TTM)
: 
3.728B  ?Debt/Equity
 (TTM)
: 
23.64
?P/B
 (TTM)
: 
6.12  ?Current Ratio
 (TTM)
: 
0.49

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about ULCC valuation

Is Frontier Group Holdings, Inc. (ULCC) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Frontier Group Holdings, Inc. (ULCC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ULCC a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ULCC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ULCC’s P/E ratio?

You can see ULCC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ULCC?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ULCC a good long-term investment?

Whether ULCC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

ULCC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

6.01
MARKETSnap

Trading Metrics:

Open: 6.11   Previous Close: 5.99
Day Low: 5.87   Day High: 6.5
Year Low: 3.02   Year High: 6.66
Price Avg 50: 4.52   Price Avg 200: 4.6
Volume: 4.641M   Average Volume: 5.701M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

International Frontier Resources Corporation and Kinjal Corporation Announce Upsize of Brokered Equity Financing to C$40 Million
09-06-2026 13:54
International Frontier Resources Corporation and Kinjal Corporation Announce Upsize of Brokered Equity Financing to C$40 Million
New Frontier Minerals to Commence Metallurgical Testwork at Pomme REE Project
09-06-2026 10:25
New Frontier Minerals to Commence Metallurgical Testwork at Pomme REE Project
Cognizant Develops Frontier Certified Engineer and Frontier Business Operator Roles to Define the Next Generation of AI-Powered Work
01-06-2026 10:00
Cognizant Develops Frontier Certified Engineer and Frontier Business Operator Roles to Define the Next Generation of AI-Powered Work
BrightNight Announces Financial Close for Frontier, a 120 MW Solar Project Delivering Clean Power to Kentucky
26-05-2026 12:20
BrightNight Announces Financial Close for Frontier, a 120 MW Solar Project Delivering Clean Power to Kentucky
International Frontier Resources Corporation and Kinjal Corporation Provide Transaction Update on Debt Facility, Proposed Mexican Asset Transactions and New Board Additions
25-05-2026 09:30
International Frontier Resources Corporation and Kinjal Corporation Provide Transaction Update on Debt Facility, Proposed Mexican Asset Transactions and New Board Additions
Water Tower Research Publishes Initiation of Coverage Report on NurExone Biologic, Inc., “A Novel Exosome Therapy Platform at the Frontier of CNS Regeneration”
21-05-2026 14:30
Water Tower Research Publishes Initiation of Coverage Report on NurExone Biologic, Inc., “A Novel Exosome Therapy Platform at the Frontier of CNS Regeneration”

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read